From the 2nd European CAR T-cell Meeting in Sitges, Spain, Ulrich Jäger, MD, Medical University of Vienna, Vienna, Austria, outlines a country-wide selection algorithm that is being implemented in order to better select appropriate patients for CAR T-cell therapy. The advent of common scientific programs has also enabled patients to get easier access to clinical studies amongst other benefits.
From the 2nd European CAR T-cell Meeting in Sitges, Spain, Ulrich Jäger, MD, Medical University of Vienna, Vienna, Austria, outlines a country-wide selection algorithm that is being implemented in order to better select appropriate patients for CAR T-cell therapy. The advent of common scientific programs has also enabled patients to get easier access to clinical studies amongst other benefits.
0 Comments